Palavras-chave
Como Citar
Resumo
This research project aims to conduct a literature review on the use of cannabidiol (CBD) in pediatric dental patients diagnosed with Autism Spectrum Disorders (ASD). The focus will be on the intersection between pediatric dentistry and ASD treatment, aiming to fill a substantial gap in the scientific and clinical understanding of the subject. The integrated approach provides a solid foundation for informed decision-making by healthcare professionals, family members, and caregivers. The central problem of the research lies in the need for substantial evidence supporting the efficacy and safety of CBD in this specific patient group. The absence of reliable data poses significant challenges for making informed decisions about the pediatric dental treatment of children with ASD, impacting the quality of life for these patients. Therefore, the adopted methodology will involve a literature search, using exclusively recently published articles from the last 5 years, available in databases such as PUBMED and SCIELO, among other relevant sources. The main objective of this literature review is to assess the efficacy of CBD in managing symptoms associated with ASD in pediatric dental contexts, considering its potential therapeutic benefits and possible side effects. The research aims to fill this gap by establishing a comprehensive investigation into the use of CBD in children with ASD, directing its attention to specific implications for oral health.
Referências
ATALAY, Sinemyiz; JAROCKA-KARPOWICZ, Iwona; SKRZYDLEWSKA, Elzbieta. Antioxidative and anti-inflammatory properties of cannabidiol. Antioxidants, v. 9, n. 1, p. 21, 2019.
CAMPOS, Maria Graça et al. Potential Drug Interactions with Cannabinoids in Selected Chronic Diseases: Epilepsy, Autism Spectrum Disorders, Oncology, Multiple Sclerosis and Pain. 2024.
DA COSTA, Vittória Valentina Papin et al. The effect of cannabidiol in the treatment of behavioral symptoms in children and adolescents with autism: an integrative review: O efeito do canabidiol no tratamento de sintomas comportamentais em crianças e adolescentes com autismo: uma revisão integrativa. Concilium, v. 24, n. 9, p. 364-377, 2024.
DE JESUS, Oliver Renê Viana et al. Surgical efficacy of bone grafts and GTR on endodontic microsurgery: An overview of bone regeneration technology applied in magnification. Research, Society and Development, v. 13, n. 3, p. e10013345212-e10013345212, 2024.
DE OLIVEIRA, Marianne Lira; DE OLIVEIRA, Rita Patrícia Machado. DIFICULDADES RELACIONADAS À ASSISTÊNCIA AO AUTISTA NUMA UNIDADE BÁ-SICA DE SAÚDE. ANAIS DO II SIMPÓSIO PIAUIENSE MULTIPROFISSIONAL EM NEUROPE-DIATRIA E NEONATOLOGIA, 2020., p. 50.
ERNSEN, Andressa Fátima da Silva; PEREIRA, Kleber Fernando; SABEC-PEREIRA, Dayane Kelly. Analysis of records on psychopharmacotherapy associated with Autism Spectrum Disorder corombities. 2023.
BABAYEVA, Mariana et al. Autism and associated disorders: cannabis as a potential therapy. Frontiers in Bioscience-Elite, v. 14, n. 1, p. 1, 2022.
FAMP, XIII MOSTRA CIENTÍFICA. XIII MOSTRA CIENTÍFICA DA FAMP. ANAIS DA MOSTRA CIENTÍFICA DA FAMP, v. 5, n. 1, 2022.
FERNANDES, Catarina Alexandra Trevas Madaleno. Abordagem do paciente epilético no contexto médico-dentário. 2023. Tese de Doutorado. Egas Moniz School of Health.
GHARIB, Sharareh et al. Effect of Dedicated Lactation Support Services on Breastfeeding Outcomes in Extremely-Low-Birth-Weight Neonates. J. Hum. Lact. v. 34, n. 4, p. 728-736, nov. 2018.
HACOHEN, Micha et al. Children and adolescents with ASD treated with CBD-rich cannabis exhibit significant improvements particularly in social symptoms: an open label study. Translational Psychiatry, v. 12, n. 1, p. 375, 2022.
HOUTROW, Amy J. et al. Prenatal Repair of Myelomeningocele and School-age Functional Outcomes. Pediatrics, v. 145, n. 2, 2020.
KARMUR, Brij S.; KULKARNI, Abhaya V. Medical and socioeconomic predictors of quality of life in myelomeningocele patients with shunted hydrocephalus. Child's Nervous System, v. 34, n. 4, p. 741-747, 2018.
LAM, Phoebe PY et al. Oral health status of children and adolescents with autism spectrum disorder: A systematic review of case-control studies and meta-analysis. Autism, v. 24, n. 5, p. 1047-1066, 2020.
LULLO, Brett et al. Predictors of Walking Activity in Children and Adolescents With Myelomeningocele. Archives of Physical Medicine and Rehabilitation, v. 101, n. 3, p. 450-456, 2020.
LOSS, Cassio Morais et al. Is cannabidiol during neurodevelopment a promising therapy for schizophrenia and autism spectrum disorders?. Frontiers in pharmacology, v. 11, p. 635763, 2021.
MARINHO, Alexandre Magno da Nóbrega; SILVA, Ricardo Wagner Gomes da. Anti-inflammatory effects of cannabinoids. BrJP, v. 6, n. Suppl 1, p. 31-37, 2023.
MANDOLINI, G. M. et al. Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview. Epidemiology and psychiatric sciences, v. 27, n. 4, p. 327-335, 2018.
MIMURA, Paula Maria Preto; FERREIRA, Lisiane Seguti; PEREIRA, Carla Leal. Cannabinoids for the treatment of autism and childhood epilepsy. BrJP, 2023.
MINELLA, Flávia Cristina Osaku; LINARTEVICHI, Vagner Fagnani. Efeitos do canabidiol nos sinais e comorbidades do transtorno do espectro autista. Research, Society and Development, v. 10, n. 10, p. e64101018607-e64101018607, 2021.
SABO, Helena Wohlers; BAPTISTA, Ana Gabriela. Neuropathies and the use of cannabinoids as a therapeutic strategy. BrJP, 2023.
SILVA JUNIOR, Estácio Amaro da et al. Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: randomized, double-blind, and placebo-controlled clinical trial. Trends in Psychiatry and Psychotherapy, v. 46, p. e20210396, 2024.
SILVA, Hygor Kleber Cabral; LOURENCO, Rafaela Fernandes. Cannabinoid therapy within the Unified Health System, perspectives in relation to pain treatment. BrJP, v. 6, p. 44-48, 2023.
SNYDER, Hannah. Designing the literature review for a strong contribution. Journal of Decision Systems, p. 1-8, 2023.
SUNDA, Falone; AROWOLO, Afolake. A molecular basis for the anti‐inflammatory and anti‐fibrosis properties of cannabidiol. The FASEB Journal, v. 34, n. 11, p. 14083-14092, 2020.
TERTULIANO, P. H. A. .; PEREIRA, I. C. .; ROCHA SOBRINHO, H. M. O uso de canabidiol como terapia complementar no transtorno do espectro autista. REVISTA BRASILEIRA MILITAR DE CIÊNCIAS, [S. l.], v. 7, n. 18, 2021.
PEDRAZZI, João FC et al. Cannabidiol for the treatment of autism spectrum disorder: hope or hype?. Psychopharmacology, v. 239, n. 9, p. 2713-2734, 2022.
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Anna Karolliny Costa Bertoldi , Walter Bertoldi Neto , Andres Camilo Campo Arevalo , Bárbara Sttephanny Silveira Santos , Filipe de Souza Nunes